SANO trial: What do patients with esophagus cancer value?
Krishan Jethw, Nina Niu Sanford and Vinay Prasad shared some insights on the SANO trial on X/Twitter:
“SANO-trial!! Been waiting for this one! Patients with esophagus ACA with cCR after CRT randomized to active surveillance vs. esophagectomy. Non-inferior OS and improved QoL with AS approach! Looking forward to manuscript to unpack the details.”
Source: Krishan Jethwa/X
“What do patients with esophagus cancer value?
In this study (n=100), patients were willing to accept a 16% decrement in 5-year OS for an opportunity to undergo an active surveillance regimen after neoadjuvant chemoRT. Therefore, with SANO showing similar OS and better QOL with organ preservation (deets/confirmation pending presentation in a few days), active surveillance should be a standard of care for patients with esophagus cancer achieving a complete response to chemoradiotherapy.”
Source: Nina Niu Sanford/X
“Incredible study. Patients willing to accept 16% loss of survival (aka massive) to lower getting surgery by 66%. Honestly, having seen the surgeries, me too! The real lesson is patients care about BIG OS diffs and not the piddly (2 mo PFS/ OS) that FDA permits from pharma.”
Source: Vinay Prasad/X
SANO trial results are published as “Patients’ preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer” by
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:17 27/11Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows